Skip to main content
Clinical Trials/NCT01226342
NCT01226342CompletedNot Applicable

Transcutaneous Electrical Muscle Stimulation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

The University Clinic of Pulmonary and Allergic Diseases Golnik2 sites in 1 country19 target enrollmentStarted: January 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
19
Locations
2
Primary Endpoint
Scores on the feasibility scale

Study Overview

Brief Summary

Transcutaneous electrical muscle stimulation (TCEMS) is well established intervention for rehabilitation of clinically stable patients with chronic obstructive pulmonary disease.

The investigators have conceived this study to test whether TCEMS is feasible and tolerated by patients experiencing severe physical and psychical challenge of acutely exacerbated COPD.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
35 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • chronic obstructive pulmonary disease GOLD stage III or IV
  • acute exacerbation of the disease

Exclusion Criteria

  • contraindications for transcutaneous electrical muscle stimulation

Outcomes

Primary Outcomes

Scores on the feasibility scale

Time Frame: 10 days (avarage time from admission to discharge)

Patients will be followed from admission until discharge

Secondary Outcomes

  • Scores on the patient satisfaction scale(10 days (avarage time from admission to discharge))
  • Number of patients with adverse events as a measure of Safety and tolerability(10 days (avarage time from admission to discharge))
  • Health related quality of life on the St. George respiratory questionnaire(10 days (avarage time from admission to discharge))
  • Dyspnea on the MRC dyspnea scale(10 days (avarage time from admission to discharge))
  • Patient symptom scores on the Functional assessment of chronic illness therapy questionaire(10 days (avarage time from admission to discharge))

Investigators

Sponsor
The University Clinic of Pulmonary and Allergic Diseases Golnik
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mitja Lainščak

Professor

The University Clinic of Pulmonary and Allergic Diseases Golnik

Study Sites (2)

Loading locations...

Similar Trials